Source: International Congress 2018 – Physiological and biological insights in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Tokunaga (Kurume, Japan), H. Imaoka (Kurume, Japan), Y. Morimatsu (Kurume, Japan), Y. Kaku (Kurume, Japan), Y. Sakazaki (Kurume, Japan), M. Matsuoka (Kurume, Japan), Y. Komohara (Kumamoto, Japan), T. Kawayama (Kurume, Japan), M. Takeya (Kumamoto, Japan), T. Hoshino (Kurume, Japan). Role of CD163 in human fatal asthma and murine asthma model.. 648

Member's Comments

No comment yet.

Related content which might interest you: Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003 Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma. Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Murine models of asthma Source: Guideline 2003 Year: 2003 Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Role of mouse mast cell protease 4 in a murine model of allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Decreased Smad7 expression in the airways of a mouse model of chronic asthma Source: Annual Congress 2004 - Animal models of allergic airway disease Year: 2004 IL-13-dependent C3a-release in a murine model of allergic asthma Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD Year: 2005 Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Analysis of mucus production in mouse models of allergic asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001